tirzepatide heart failure trial and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Management - Abdul‐Hafez - 2026 - Endocrinology, Diabetes & Metabolism Lilly says weight loss drug

NovoCare launched with Wegovy priced at $499 per month for cash-paying patients a significant reduction from the $1,349 list price, though still above what TrumpRx would later negotiate

Below are eight companies worth considering, starting with the provider that stands out for affordability, physician access, treatment flexibility, and overall patient experience

There is currently no other agent on the market for the treatment of diabetes that works by this mechanism of action

Weight regain does not happen simply because the medication stops

This creates a duopoly where the first-to-file generic, which expected six months of exclusive generic market access, instead finds itself competing against the brands own generic product from Day 1

They're addicted to rebates